Matrix metalloproteinase pattern in celiac duodenal mucosa

被引:77
作者
Ciccocioppo, R
Di Sabatino, A
Bauer, M
Della Riccia, DN
Bizzini, F
Biagi, F
Cifone, MG
Corazza, GR
Schuppan, D
机构
[1] Univ Pavia, Policlin San Matteo, IRCCS, Gastroenterol Unit, I-27100 Pavia, Italy
[2] Univ Erlangen Nurnberg, Dept Med 1, D-8520 Erlangen, Germany
[3] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy
关键词
cytokines; celiac disease; extracellular matrix; metalloproteinases; mucosal damage;
D O I
10.1038/labinvest.3700225
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Matrix metalloproteinases ( MMPs) are a family of endopeptidases playing a key role in tissue remodelling in both physiological and pathological conditions. Since little information is available about their role in celiac disease ( CD), our aims were to quantify their expression/ activity and to investigate their relation to proinflammatory cytokines in this condition. Duodenal biopsies from untreated, treated celiac patients and controls were used to quantify the expression of MMP- 1, MMP- 2, MMP- 3, MMP- 9, MMP- 12, MMP- 14, their inhibitor TIMP- 1, IFN-gamma and TNF-alpha by using real- time reverse transcription- polymerase chain reaction and the gelatin/ casein/ elastin activities by gel zymography, and to isolate lamina propria mononuclear cells ( LPMCs). These cells and myofibroblasts isolated from jejunal specimens were incubated in the absence or presence of IFN-gamma and TNF-alpha. MMP- 1 and MMP- 12 mRNA levels were significantly increased in active CD compared to treated ( P < 0.01 and P < 0.0005, respectively) and normal mucosa ( P < 0.01 and P < 0.0005, respectively), and this was paralleled by an upregulation of caseinolytic and elastolytic activities. Furthermore, MMP- 12 levels significantly ( P < 0.05) correlated with those of IFN-gamma and the degree of villous flattening. MMP- 2 turned out to be significantly ( P < 0.05) reduced in untreated and treated celiacs compared to controls. In active CD, transcripts of TIMP- 1 were higher than in treated and controls ( P < 0.005 and P < 0.05, respectively), such as those of IFN-gamma ( P < 0.05), whereas TNF-alpha levels were suppressed ( P = 0.0001). In physiological condition, myofibroblasts represent the main source of MMP- 2, whereas LPMCs produce almost all MMPs only after cytokine stimulation. Conversely, cells isolated from active patients constitutively express MMPs without any increase after cytokine stimulation, while those from treated patients are in a resting condition. In conclusion, our results show the presence of a peculiar MMP pattern in active CD strongly dominated by MMP- 12, correlating either with IFN-gamma or the degree of mucosal damage.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 40 条
[21]   Spreading and focusing of gluten epitopes in celiac disease [J].
Martucci, S ;
Corazza, GR .
GASTROENTEROLOGY, 2002, 122 (07) :2072-2075
[22]   Enhancing lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury [J].
Monteleone, G ;
MacDonald, TT ;
Wathen, NC ;
Pallone, F ;
Pender, SLF .
GASTROENTEROLOGY, 1999, 117 (05) :1069-1077
[23]  
Monteleone G, 2001, EUR J IMMUNOL, V31, P2247, DOI 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO
[24]  
2-4
[25]  
MOWAT AM, 1989, IMMUNOLOGY, V68, P18
[26]   Matrix metalloproteinases [J].
Nagase, H ;
Woessner, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) :21491-21494
[27]   Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease [J].
Nilsen, EM ;
Jahnsen, FL ;
Lundin, KEA ;
Johansen, FE ;
Fausa, O ;
Sollid, LM ;
Jahnsen, J ;
Scott, H ;
Brandtzaeg, P .
GASTROENTEROLOGY, 1998, 115 (03) :551-563
[28]   Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation [J].
Pender, SLF ;
Lionetti, P ;
Murch, SH ;
Wathan, N ;
MacDonald, TT .
GUT, 1996, 39 (02) :284-290
[29]  
Pender SLF, 1997, J IMMUNOL, V158, P1582
[30]   HISTOLOGICAL-CHANGES IN SMALL-BOWEL MUCOSA INDUCED BY GLIADIN SENSITIVE T-LYMPHOCYTES CAN BE BLOCKED BY ANTIINTERFERON-GAMMA ANTIBODY [J].
PRZEMIOSLO, RT ;
LUNDIN, KEA ;
SOLLID, LM ;
NELUFER, J ;
CICLITIRA, PJ .
GUT, 1995, 36 (06) :874-879